Primo Chemicals sets Sep 23 record date for AGM e-voting

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Record date for AGM e-voting is September 23, 2026
  • 51st AGM scheduled for September 30, 2026 via video conference
  • Register of members closed from September 24 to September 30, 2026
  • Disclosure made under SEBI LODR Regulation 42
powered bylight_fuzz_icon
49730934

*this image is generated using AI for illustrative purposes only.

Primo Chemicals has fixed September 23, 2026 as the record date for remote e-voting ahead of its 51st Annual General Meeting. The meeting is scheduled for September 30, 2026.

The company announced that the Register of Members and Share Transfer Books will remain closed for seven days. This closure period runs from Thursday, September 24, 2026 to Wednesday, September 30, 2026, both days inclusive.

Meeting Details

The AGM will be held on September 30, 2026 at 2:00 pm through Video Conferencing or other Audio Visual Means. This follows an earlier notification issued on August 14, 2026 regarding the meeting schedule.

Voting Entitlements

Shareholders holding shares on the record date of September 23, 2026 are eligible to vote. This entitlement covers both remote e-voting, including m-voting, and voting conducted during the AGM itself.

The disclosure was made pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Primo Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.98%+1.10%-5.38%+12.82%-18.83%0.0%

What specific resolutions or strategic initiatives are expected to be tabled at Primo Chemicals' 51st AGM?

How might the seven-day closure of share transfer books impact short-term liquidity and trading volume for the stock?

Are there any anticipated changes to the board of directors or management team to be discussed during the meeting?

Primo Chemicals Q1 Results: Net profit rises 16% YoY to ₹36 million

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Primo Chemicals delivered a positive Q1 result with net profit jumping 16% YoY to ₹36 million. The gain was fueled by a 46 bps expansion in EBITDA margin to 14.83%, as EBITDA rose to ₹208 million. Revenue held steady at ₹1.4 billion, showing that profit growth stemmed from efficiency rather than top-line expansion.

powered bylight_fuzz_icon
48257701

*this image is generated using AI for illustrative purposes only.

Primo Chemicals reported a rise in quarterly profitability for the first quarter, driven by improved operating margins despite flat top-line growth. The company’s net profit increased 16% year-on-year to ₹36 million, up from ₹31 million in the corresponding period last year.

Operating performance showed clear signs of efficiency gains. EBITDA grew slightly to ₹208 million from ₹204 million YoY. More significantly, the EBITDA margin expanded by 46 basis points to 14.83%, compared to 14.37% in the prior year quarter. This margin expansion occurred even as revenue remained unchanged at ₹1.4 billion, indicating better cost management or product mix optimization rather than volume-driven growth.

Financial Highlights

Metric: Q1 Current Q1 Prior Year Change
Revenue: ₹1.4 billion ₹1.4 billion Flat
EBITDA: ₹208 million ₹204 million +2%
EBITDA Margin: 14.83% 14.37% +46 bps
Net Profit: ₹36 million ₹31 million +16%

What the Numbers Show

The divergence between flat revenue and expanding margins suggests operational leverage. While sales did not grow, the company managed to increase absolute EBITDA and significantly widen its margin percentage. This indicates that costs were controlled effectively relative to revenue, allowing a larger portion of the fixed revenue base to flow through to operating profit. The subsequent jump in net profit (16%) outpacing the EBITDA growth (2%) further highlights the impact of this margin improvement on the bottom line.

Historical Stock Returns for Primo Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-0.98%+1.10%-5.38%+12.82%-18.83%0.0%

Can Primo Chemicals sustain this margin expansion trajectory in Q2 and beyond, or was it a one-time benefit from specific cost controls?

What specific product mix shifts or pricing strategies contributed to the improved operating leverage despite flat top-line revenue?

How does the current EBITDA margin of 14.83% compare to industry peers, and is there room for further improvement through operational efficiency?

More News on Primo Chemicals

1 Year Returns:-18.83%